These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38971568)

  • 1. PDK4-mediated Nrf2 inactivation contributes to oxidative stress and diabetic kidney injury.
    Tian S; Yang X; Lin Y; Li X; Zhou S; Yu P; Zhao Y
    Cell Signal; 2024 Sep; 121():111282. PubMed ID: 38971568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
    Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway.
    Liu Y; Wang S; Jin G; Gao K; Wang S; Zhang X; Zhou K; Cai Y; Zhou X; Zhao Z
    Phytomedicine; 2023 Sep; 118():154915. PubMed ID: 37392674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing Oxidative Stress and Inflammation by Pyruvate Dehydrogenase Kinase 4 Inhibition Is Important in Prevention of Renal Ischemia-Reperfusion Injury in Diabetic Mice.
    Khang AR; Kim DH; Kim MJ; Oh CJ; Jeon JH; Choi SH; Lee IK
    Diabetes Metab J; 2024 May; 48(3):405-417. PubMed ID: 38311057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
    Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
    Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.
    Xiao L; Xu X; Zhang F; Wang M; Xu Y; Tang D; Wang J; Qin Y; Liu Y; Tang C; He L; Greka A; Zhou Z; Liu F; Dong Z; Sun L
    Redox Biol; 2017 Apr; 11():297-311. PubMed ID: 28033563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 deficiency deteriorates diabetic kidney disease in Akita model mice.
    Liu Y; Uruno A; Saito R; Matsukawa N; Hishinuma E; Saigusa D; Liu H; Yamamoto M
    Redox Biol; 2022 Dec; 58():102525. PubMed ID: 36335764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
    Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
    Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives.
    Tanase DM; Gosav EM; Anton MI; Floria M; Seritean Isac PN; Hurjui LL; Tarniceriu CC; Costea CF; Ciocoiu M; Rezus C
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease.
    Shen Q; Fang J; Guo H; Su X; Zhu B; Yao X; Wang Y; Cao A; Wang H; Wang L
    Free Radic Biol Med; 2023 Jul; 203():45-57. PubMed ID: 37030337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SP600125 suppresses
    Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H
    J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
    Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
    Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stress response protein REDD1 promotes diabetes-induced oxidative stress in the retina by Keap1-independent Nrf2 degradation.
    Miller WP; Sunilkumar S; Giordano JF; Toro AL; Barber AJ; Dennis MD
    J Biol Chem; 2020 May; 295(21):7350-7361. PubMed ID: 32295843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition.
    Wu Z; Li D; Tian D; Liu X; Wu Z
    PLoS One; 2022; 17(12):e0279010. PubMed ID: 36516169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation.
    Wang X; Li C; Huan Y; Cao H; Sun S; Lei L; Liu Q; Liu S; Ji W; Huang K; Shen Z; Zhou J
    Chem Biol Interact; 2021 Apr; 338():109427. PubMed ID: 33639173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
    Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
    Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21.
    Wu H; Kong L; Tan Y; Epstein PN; Zeng J; Gu J; Liang G; Kong M; Chen X; Miao L; Cai L
    Diabetologia; 2016 Jul; 59(7):1558-1568. PubMed ID: 27115417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats.
    Zhang L; Wang X; Chang L; Ren Y; Sui M; Fu Y; Zhang L; Hao L
    Ren Fail; 2024 Dec; 46(1):2327495. PubMed ID: 38465879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway.
    Lu Q; Yang L; Xiao JJ; Liu Q; Ni L; Hu JW; Yu H; Wu X; Zhang BF
    Free Radic Biol Med; 2023 Feb; 195():89-102. PubMed ID: 36581059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.